Hooper Holmes responded to the proposal of shareholders

 

Thursday, Apr 16,2009, 1:31:38 PM   Click:

Basking Ridge, NJ - (MARKET WIRE) - 04/15/09 - Hooper Holmes (NYSE AMEX: HH) today announced that it has considered the proposals contained in the preliminary proxy statement filed by Ron Aprahamian, 15 April 2009. The company reaffirmed its support for the election of Roy Lowrance and Leslie Hudson to serve as members of the Company Board of Directors. Both Mr. Lowrance and Dr. Hudson were recommended by the Governance Committee and Nominating Committee and appointed by Hooper Holmes Board of Directors on the basis of their qualifications, experience and leadership.

Hooper Holmes is committed to providing value and transparency to its shareholders. The company manages its business to profitability, and believes it is positioned for future growth of each of its businesses. Hooper Holmes is preparing communications to shareholders regarding its support for the election of Mr. Lowrance and Dr. Hudson, along the League of recommendations that Mr. Aprahamian candidates to be elected to the Corporation Board of Directors. This communication will be filed with the Securities and Exchange Commission and mailed to all shareholders eligible to vote at the annual meeting.

About Hooper Holmes

Hooper Holmes is the leader in collecting personal health data and transforming it into useful information, allowing customers to take actions that manage or reduce their risks and expenses. As the leading provider of risk assessment for the insurance industry, insurers Hooper Holmes provides the widest range of medical exam, data collection, laboratory testing and underwriting services to industry.

With presence in over 250 markets and a network of thousands of examiners, Hooper Holmes can arrange a medical exam anywhere in the United States and results to its clients. Each year we arrange more medical exams than any other company and process 3.8 million specimens in our laboratory. We offer a complete service for wellness, disease management and care management support, including planning, provision of supplies, kits, blood collection, medical screenings, lab testing and data transmission. We underwrite 300,000 cases annually and complete more than two million telephone interviews.


This press release contains "forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations of society and beliefs and are subject to a number of risks, uncertainties and assumptions. Important factors that could cause actual results to differ materially from those expressed or implied by, these forward-looking statements are our ability to successfully implement our business strategy, the uncertainty regarding our capital requirements to Over the next 12 to 24 months, our ability to maintain compliance with financial covenants in our credit facility, our expectations regarding our cash flow and the rate of life insurance business. Additional information about these and other factors that could affect the Company's business is described in the annual report of the Company on Form 10-K for the year ended 31 December 2008, filed with the Securities and Exchange Commission March 16 2009. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this release to reflect the occurrence of unanticipated events, except as required by law.

For more information contact: Roy H. Hooper Holmes Bubbs President and CEO (908) 766-5000 Investors: Andrew Berger SM Berger & Company (216) 464-6400